HORIZON 2020 - An inside view of arthritis

Arthritis is very common - so common, indeed, that aching joints may seem inevitable as we age. They are not, of course, and even if the condition does set in, treatment can often slow it down. MRI combined with nanoparticles developed by an EU-funded project could soon help to spot main forms of the disease much earlier.

Related topics

Health Innovation Health, Demographic Change and Wellbeing Nanotechnologies Austria Estonia France Germany Netherlands Sweden Switzerland

date: 15/02/2016

Project: Development of novel nanotechnology base...

acronym: NANODIARA

See also: CORDIS

The NanoDiaRA project developed a nanoparticle-based system for the detection of osteoarthritis and rheumatoid arthritis, the two most common forms of the disease, which is a leading cause of pain and disability. “Our particles are designed for use as a contrast agent in magnetic resonance imaging [MRI],” says scientific coordinator Dr Margarethe Hofmann of MatSearch Consulting Hofmann in Switzerland.

Read more